TDC
IRWD icon

Thompson Davis & Co’s Ironwood Pharmaceuticals IRWD Stock Holding History

Thompson Davis & Co’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$45K Hold
2,925
– – 0.1% 217
2018
Q2 		$47K Buy
+2,925
New +$43.3K 0.11% 199

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Thompson Davis & Co's IRWD Position: Q3 2018 in Review

Thompson Davis & Co held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2018 at 2,925 shares worth $45K. The position accounts for 0.1% of the portfolio, ranked #217.

Thompson Davis & Co first reported a position in IRWD in Q2 2018 and has held it in 2 quarters since. The position peaked at $47K in Q2 2018. 151 funds tracked by Wall St. Rank hold IRWD as of Q3 2018.

  • Thompson Davis & Co held 2,925 shares of Ironwood Pharmaceuticals worth $45K as of Q3 2018.
  • Thompson Davis & Co left its Ironwood Pharmaceuticals share count unchanged in Q3 2018.
  • Ironwood Pharmaceuticals made up 0.1% of Thompson Davis & Co's portfolio in Q3 2018, its #217 holding.
  • Thompson Davis & Co first reported a position in Ironwood Pharmaceuticals in Q2 2018 and has held it in 2 quarters since.
  • Thompson Davis & Co's Ironwood Pharmaceuticals position peaked at $47K in Q2 2018.
  • 151 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.